⌘K

Home/Filings/4/0001077183-21-000089

4//SEC Filing

Brown Douglas Matthew 4

Accession 0001077183-21-000089

CIK 0001077183other

View on SEC.gov Company Profile

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 9:06 PM ET

Size

8.1 KB

Accession

0001077183-21-000089

Insider Transaction Report

Form 4

Period: 2021-03-02

NEOGENOMICS INCNEO

Brown Douglas Matthew

Chief Strategy Officer

Transactions

Award
Common Stock
2021-03-02+4,655→ 111,644 total
Award
Stock Option (Right to Buy)
2021-03-02$53.17/sh+26,378$1,402,518→ 26,378 total
Exercise: $53.17Exp: 2028-03-02→ Common Stock (26,378 underlying)

Holdings

Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (45,017 underlying)
0

Footnotes (2)

[F1]On March 2, 2020, Mr. Brown was granted 45,017 stock options. These options vest ratably over the first four anniversary dates of the grant date.
[F2]On March 2, 2021, Mr. Brown was granted 26,378 stock options. These options vest ratably over the first four anniversary dates of the grant date.

Documents

1 file

4
wf-form4_161490996623773.xmlPrimary
FORM 4

Issuer

NEOGENOMICS INC

CIK 0001077183

Entity typeother

Related Parties

1

filerCIK 0001849414

Filing Metadata

Form type: 4
Filed: Mar 3, 7:00 PM ET
Accepted: Mar 4, 9:06 PM ET
Size: 8.1 KB

View on SEC.gov